ArticleRheumatology advances in practice2026
The SLICC/ACR damage index, assessed using a community-based electronic healthcare record, predicts mortality in SLE patients: results from the United Kingdom Clinical Practice Research Datalink.
Article in Rheumatology advances in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: SLE, the exemplar autoimmune multisystem disease, is still burdened by excess morbidity and mortality. Damage is a key mediator of this. Studies of damage in outside-of-hospital cohorts are lacking, limiting understanding of real-world patient outcomes. The objectives were thus to design an instrument for measurement of SLE organ damage (eSDI) usable within a UK electronic primary care healthcare database [Clinical Practice Research Datalink (CPRD)] and describe the accrual of damage and mortality associations in an SLE cohort. Methods: A cohort of SLE individuals, including incident and prevalent cases, was identified in the CPRD. Organ damage item definitions were made usable for the electronic registry setting. Prevalence of damage in the overall cohort was described using descriptive statistics. Associations with mortality and damage (expressed in two ways, SDI > 0 ever, or modelled as a continuous cumulative variable) were examined using multivariable logistic regression, Kaplan-Meier analysis and extended Cox proportional hazards analysis in the incident SLE population. Results: We identified 8363 SLE patients in total, of whom the eSDI measured damage in 3537 (42.3%). The most common items were osteoporosis (10.39%), malignancy (8.4%) and cataract (7.4%). Damage across all organ systems was associated with an increased odds of death (e.g. malignancy [odds ratio 6.33 (95% CI 5.34, 7.49)]. Development of damage (eSDI >0 or as a numerical damage score) was significantly associated with an increased hazard of mortality. Conclusion: The use of an adapted eSDI for community electronic health records is feasible and enables widening of the study of damage and its morbidity and mortality consequences to primary care populations. This is more likely to reflect the real-world accumulation and outcomes of damage over time in SLE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.